22 related articles for article (PubMed ID: 38581717)
1. Integrated pan-cancer analysis reveals the immunological and prognostic potential of RBFOX2 in human tumors.
Huang F; Jin L; Zhang X; Wang M; Zhou C
Front Pharmacol; 2024; 15():1302134. PubMed ID: 38881877
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive pan-cancer analysis reveals VSIR as a candidate immunologic, diagnostic, and prognostic biomarker.
Pan J; Mahsud I; Ul Haq M; Khan S; Alhomrani M; Alamri AS; Alghamdi SA; ALSuhaymi N; Baothman BK; Almaghrabi S; Ullah S; Jamil M
Am J Transl Res; 2024; 16(5):1630-1642. PubMed ID: 38883368
[TBL] [Abstract][Full Text] [Related]
3. Pan-Cancer Analysis and Experimental Validation of CEND1 as a Prognostic and Immune Infiltration-Associated Biomarker for Gliomas.
Ma J; Lang B; Wang L; Zhou Y; Fu C; Tian C; Xue L
Mol Biotechnol; 2024 Jun; ():. PubMed ID: 38836983
[TBL] [Abstract][Full Text] [Related]
4. Pancancer Analysis of NSUN2 with a Focus on Prognostic and Immunological Roles in Endometrial Cancer.
Zan Y; Ding Y
Reprod Sci; 2024 Jun; ():. PubMed ID: 38900401
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive pan-cancer analysis reveals the versatile role of GALNT7 in epigenetic alterations and immune modulation in cancer.
Liu Y; Sun Y; Xiao M; Li S; Shi S
Heliyon; 2024 Jun; 10(11):e31515. PubMed ID: 38845941
[TBL] [Abstract][Full Text] [Related]
6. NALCN is a potential biomarker and therapeutic target in human cancers.
He J; Xu J; Chang Z; Yan J; Zhang L; Qin Y
Front Genet; 2023; 14():1164707. PubMed ID: 37152978
[No Abstract] [Full Text] [Related]
7. Pan-cancer analysis of the prognostic and immunological roles of
Liu S; Liu Y; Zhang X; Song X; Zhang B; Zhang Y
Front Genet; 2022; 13():1039440. PubMed ID: 36313454
[No Abstract] [Full Text] [Related]
8. A Comprehensive Pan-Cancer Analysis Reveals Cyclin-Dependent Kinase Inhibitor 2A Gene as a Potential Diagnostic and Prognostic Biomarker in Colon Adenocarcinoma.
Salem A; Ahmed S; Khalfallah M; Hamadan N; ElShikh W; Alfaki M
Cureus; 2024 May; 16(5):e60586. PubMed ID: 38894777
[TBL] [Abstract][Full Text] [Related]
9. Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy.
Jia Y; Guo B; Zhang W; Wang F; Zhang Y; Zhang Q; Li E
Front Oncol; 2023; 13():1110207. PubMed ID: 37427102
[TBL] [Abstract][Full Text] [Related]
10. A pancancer analysis of histone deacetylase 3 in human tumors.
Chen H; Xu F; Qin A; Guo S; Zhang G; Yu B; Zheng Q
Transl Cancer Res; 2024 Jan; 13(1):65-80. PubMed ID: 38410236
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive analysis of the prognostic and immunological role of
Tan Y; Meng W; Jiang Z; Li N; Zhang T; Zhang J; Ma L; Guan Y
Transl Cancer Res; 2024 Feb; 13(2):1091-1113. PubMed ID: 38482441
[TBL] [Abstract][Full Text] [Related]
12. Cyclin B1: A potential prognostic and immunological biomarker in pan-cancer.
Chen Q; Ouyang L; Liu Q
Biomol Biomed; 2024 Apr; ():. PubMed ID: 38581717
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
